163 related articles for article (PubMed ID: 21916832)
41. [Splenic T-cell and NK-cell lymphomas: a clinicopathologic and immunophenotypic analysis of 9 cases].
Li Z; Liu WP; Tang Y; Jiang LL; Zhang WY; Bi CF; Li GD
Zhonghua Xue Ye Xue Za Zhi; 2007 Apr; 28(4):217-22. PubMed ID: 17877195
[TBL] [Abstract][Full Text] [Related]
42. Flow cytometric features of angioimmunoblastic T-cell lymphoma.
Chen W; Kesler MV; Karandikar NJ; McKenna RW; Kroft SH
Cytometry B Clin Cytom; 2006 May; 70(3):142-8. PubMed ID: 16572417
[TBL] [Abstract][Full Text] [Related]
43. [Clinicopathologic study of hepatosplenic T-cell lymphoma].
Zhang S; Nong L; Ren YL; Li T
Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Aug; 40(4):387-91. PubMed ID: 18677385
[TBL] [Abstract][Full Text] [Related]
44. [A case of hepatosplenic gammadelta T cell lymphoma].
Wang FX; Zhang XJ; Dong ZR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Jun; 13(3):505-8. PubMed ID: 15972153
[TBL] [Abstract][Full Text] [Related]
45. Diagnosis of peripheral T-cell lymphoma by fine-needle aspiration biopsy: a cytomorphologic and immunophenotypic approach.
Al Shanqeety O; Mourad WA
Diagn Cytopathol; 2000 Dec; 23(6):375-9. PubMed ID: 11074640
[TBL] [Abstract][Full Text] [Related]
46. Hepatosplenic gamma/delta T-cell lymphoma in immunocompromised patients. Report of two cases and review of literature.
Khan WA; Yu L; Eisenbrey AB; Crisan D; al Saadi A; Davis BH; Hankin RC; Mattson JC
Am J Clin Pathol; 2001 Jul; 116(1):41-50. PubMed ID: 11447750
[TBL] [Abstract][Full Text] [Related]
47. T-lymphoblastic lymphoma with an unusual t(8;14)(q24;q11)--case report.
Mandac I; Kolonić SO; Vrhovac R; Lasan-Trcić R; Jakelić-Pitesa J; Kardum-Skelin I
Coll Antropol; 2010 Mar; 34(1):265-9. PubMed ID: 20432760
[TBL] [Abstract][Full Text] [Related]
48. Gamma/delta T-cell posttransplantation lymphoproliferative disorder primarily in the spleen.
Ross CW; Schnitzer B; Sheldon S; Braun DK; Hanson CA
Am J Clin Pathol; 1994 Sep; 102(3):310-5. PubMed ID: 8085554
[TBL] [Abstract][Full Text] [Related]
49. Hepatosplenic gammadelta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients.
Belhadj K; Reyes F; Farcet JP; Tilly H; Bastard C; Angonin R; Deconinck E; Charlotte F; Leblond V; Labouyrie E; Lederlin P; Emile JF; Delmas-Marsalet B; Arnulf B; Zafrani ES; Gaulard P
Blood; 2003 Dec; 102(13):4261-9. PubMed ID: 12907441
[TBL] [Abstract][Full Text] [Related]
50. Isochromosome 7q: the primary cytogenetic abnormality in hepatosplenic gammadelta T cell lymphoma.
Alonsozana EL; Stamberg J; Kumar D; Jaffe ES; Medeiros LJ; Frantz C; Schiffer CA; O'Connell BA; Kerman S; Stass SA; Abruzzo LV
Leukemia; 1997 Aug; 11(8):1367-72. PubMed ID: 9264394
[TBL] [Abstract][Full Text] [Related]
51. Consistent presence of isochromosome 7q in hepatosplenic T gamma/delta lymphoma: a new cytogenetic-clinicopathologic entity.
Wang CC; Tien HF; Lin MT; Su IJ; Wang CH; Chuang SM; Shen MC; Liu CH
Genes Chromosomes Cancer; 1995 Mar; 12(3):161-4. PubMed ID: 7536454
[TBL] [Abstract][Full Text] [Related]
52. Hepatosplenic T-cell lymphoma: a rare but challenging entity.
Pro B; Allen P; Behdad A
Blood; 2020 Oct; 136(18):2018-2026. PubMed ID: 32756940
[TBL] [Abstract][Full Text] [Related]
53. Hepatosplenic γδ T-cell lymphoma: an overview.
Visnyei K; Grossbard ML; Shapira I
Clin Lymphoma Myeloma Leuk; 2013 Aug; 13(4):360-9. PubMed ID: 23876844
[TBL] [Abstract][Full Text] [Related]
54. Florid splenic γ/δ T-cell proliferation in patients with splenomegaly and cytopenias: a "high stakes" diagnostic challenge.
Zhang S; Bayerl MG
Hum Pathol; 2017 Aug; 66():216-221. PubMed ID: 28235627
[TBL] [Abstract][Full Text] [Related]
55. [Clinicopathologic features and differential diagnosis of splenic B-cell marginal zone lymphoma involving bone marrow].
Sun Q; Zhang PH; Liu EB; Liu W; Li ZQ; Yang QY; Fang LH; Sun FJ; Chen HS; Qiu LG
Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):234-8. PubMed ID: 23928529
[TBL] [Abstract][Full Text] [Related]
56. Flow cytometry in the differential diagnosis of lymphocyte-rich thymoma from precursor T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma.
Li S; Juco J; Mann KP; Holden JT
Am J Clin Pathol; 2004 Feb; 121(2):268-74. PubMed ID: 14983942
[TBL] [Abstract][Full Text] [Related]
57. Molecular features of hepatosplenic T-cell lymphoma unravels potential novel therapeutic targets.
Travert M; Huang Y; de Leval L; Martin-Garcia N; Delfau-Larue MH; Berger F; Bosq J; Brière J; Soulier J; Macintyre E; Marafioti T; de Reyniès A; Gaulard P
Blood; 2012 Jun; 119(24):5795-806. PubMed ID: 22510872
[TBL] [Abstract][Full Text] [Related]
58. Hepatosplenic T-cell lymphoma.
Raza A; Ewton A
Blood; 2014 Jul; 124(5):677. PubMed ID: 25221804
[No Abstract] [Full Text] [Related]
59. [Dermatomyositis associated with hepatosplenic gamma delta T-cell lymphoma].
Chandesris MO; Crétel-Durand E; Jean R; Rey J; Figarella-Branger D; Sainty D; Durand JM
Rev Med Interne; 2007 Aug; 28(8):552-5. PubMed ID: 17559983
[TBL] [Abstract][Full Text] [Related]
60. [Hepatosplenic gammadeltaT-cell lymphoma: a clinicopathological study].
Geng J; Zhu MG; Ding YQ; Han HX
Di Yi Jun Yi Da Xue Xue Bao; 2004 Jan; 24(1):88-90. PubMed ID: 14724108
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
